Home
Biocon Biologics

Biocon Biologics Market Share Analysis for August 2026

Read our patient story - Mrs Kumudha Raju fighting HER2-Positive breast cancer. Biosimilar Trastuzumab brings new hope to patients

Health > Biotechnology and Pharmaceuticals

Domainbioconbiologics.com

Year Founded1978

Employees5001 - 10000

Annual Revenue--

Biocon Biologics

Biocon Biologics (including company regionals)

bioconbiologics.com

See more website traffic and engagement information

Total visits to Biocon Biologics's top domains

Understand Biocon Biologics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bioconbiologics.com22.4K

See more with Sales Intelligence

Avg. visit duration in Biocon Biologics's top domains

Analyze Biocon Biologics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bioconbiologics.com00:00:29

See more with Sales Intelligence

Avg. pageviews on Biocon Biologics's top domains

See how Biocon Biologics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bioconbiologics.com2.33

See more with Sales Intelligence

Biocon Biologics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

biocon.comCompany NameBioconEmployees> 10001HQIndia, BengaluruAnnual revenue> $1BTotal visits81.9KHealth > Pharmacy

Top technologies used by Biocon Biologics

These are the website technologies, by industry, used by Biocon Biologics top domains

Payment & Currencies (13)

Cart Functionality

Social (8)

Google+ Platform

Widget (8)

Twemoji

eCommerce (6)

Swap

More Technologies

10

See all

News & Signals from Biocon Biologics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiocon Biologics Limited expanded offices to Japan, Eastern Asia, Asia on Aug 25th '26.Investors will note that this approval expands Biocon Biologics Ltd.'s commercial footprint into Japan, one of the world's largest pharmaceutical markets by value, through an exclusive distribution agreement with Sandoz K.K.

NewsBiocon Biologics Limited had revenue of $300M on Jun 1st '26.The optimism follows a robust start to the year, with Biocon's biosimilars business reporting a 16 percent year-on-year increase in revenue to Rs 2,855 crore in the June quarter.

NewsBiocon Biologics Limited identified as competitor of Celltrion, Inc..It said Biocon has gained market share in ustekinumab but has done so by pricing the product about 40% below competitors such as Celltrion.